Bayer buying Merck's consumer product lines

Merck: User-Friendly Global Recognition

Merck earnings beat on top and bottom lines, raises forecast

Merck ready to deploy Covid-19 antiviral pill upon FDA approval, CEO says

BOVILIS® Vaccines from Merck Animal Health

Merck ends COVID-19 vaccine program, cites inferior immune responses

Merck buys Idenix for $3.85 billion

Merck ends Covid vaccine program but continues work on treatments

Merck CEO: Significant Need for New Blockbuster Drugs